Who Owns Judges Scientific Company?

Judges Scientific Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Judges Scientific plc?

Understanding the ownership of Judges Scientific plc is key to grasping its strategic path and influence in the scientific instrument market. The company's journey began with its AIM listing in January 2003, raising £2 million under the name 'Judges Capital', setting its course with a 'buy and build' strategy.

Founded in 2002 by David Cicurel, the current CEO, Judges Scientific plc operates with a clear vision: to acquire and nurture niche scientific instrument businesses with strong growth prospects. The company offers strategic investment and support to its portfolio companies, which are involved in the global design, manufacture, and sale of scientific instruments.

As of August 2025, Judges Scientific plc has a market capitalization of $0.55 billion USD, ranking it as the 6917th most valuable company globally by this metric. For the fiscal year ending December 31, 2024, the company reported sales totaling £133.6 million. Further analysis of its ownership evolution, from its inception to its current major stakeholders and board structure, offers insight into its ongoing strategic expansion, including its Judges Scientific PESTEL Analysis.

Judges Scientific plc was founded in 2002 by David Cicurel, who continues to serve as its Chief Executive Officer and remains the largest individual shareholder as of June 2025. The company, initially named 'Judges Capital', commenced trading on the AIM junior exchange in January 2003, successfully raising £2 million. Hon. Alexander Hambro was among the initial four directors upon the company's listing.

Company Inception

Judges Scientific plc was established in 2002, marking the beginning of its journey in the financial sector.

Initial Funding

The company raised £2 million when it listed on the AIM junior exchange in January 2003.

Founding Directors

Hon. Alexander Hambro was one of the four founding directors at the time of the company's initial listing.

Founder's Influence

David Cicurel's continued significant shareholding highlights his foundational role and ongoing impact on the company.

Initial Strategy

The company's initial strategy involved activist investment in undervalued public companies.

Strategic Pivot

A surge in the UK small-cap index in 2003 led to a shift towards the current 'buy and build' strategy in scientific instruments.

While the precise equity distribution among founders at inception is not publicly detailed, David Cicurel's substantial ongoing stake clearly indicates his pivotal role and enduring influence in the company's trajectory. The company's initial business model focused on activist investment in undervalued public entities, aiming for restructuring and subsequent divestment to private equity firms. However, this approach proved unsustainable due to a significant upturn in the UK small-cap market during 2003. Consequently, the company adapted its strategy to its present 'buy and build' model within the scientific instrument sector, a strategic shift that has been instrumental in its subsequent growth and shaped its ownership structure. Information concerning early investors, angel financiers, or initial ownership disputes is not readily available.

Founding and Early Operations

Judges Scientific plc was established in 2002 by David Cicurel, who continues to lead the company as CEO and is its largest individual shareholder as of June 2025. The company's initial listing on the AIM market in January 2003 raised £2 million.

• Founded in 2002 by David Cicurel.
• Listed on AIM in January 2003, raising £2 million.
• Initial name was 'Judges Capital'.
• Hon. Alexander Hambro was a founding director.
• Early strategy involved activist investment.
• Pivoted to a 'buy and build' strategy in scientific instruments.

Judges Scientific SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Judges Scientific plc's journey from its AIM market IPO in January 2003, with an initial £2 million investment, to a market capitalization of £580 million by December 2024, reflects a consistent growth strategy. As of August 2025, its market capitalization is reported at $0.55 billion USD, underscoring its expansion and market presence.

The ownership structure of Judges Scientific plc is characterized by a blend of key individuals, institutional investors, and a portion of shares not held in public hands, which stood at approximately 10.55% as of June 2025. This distribution supports the company's strategic direction, which has historically prioritized a 'buy and build' approach. This strategy involves acquiring niche scientific instrument businesses and utilizing debt repayment alongside organic growth to enhance shareholder value, thereby minimizing the need for extensive share issuance and maintaining a stable ownership base. The company's acquisition pace, averaging one acquisition annually over the past three years as of July 2025, has contributed to its portfolio growth to around 25 businesses without significant founder dilution, ensuring a strong alignment between ownership and governance.

Judges Scientific Ownership Overview

Understanding who owns Judges Scientific is key to grasping its strategic direction and stability.

• The company's market capitalization reached $0.55 billion USD as of August 2025.
• David Cicurel, the CEO, is a significant shareholder.
• Institutional investors hold substantial stakes in the company.
• The 'buy and build' strategy influences ownership stability.
• For more details on its history, see the Brief History of Judges Scientific.

Judges Scientific PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Board of Directors for Judges Scientific plc, as of early 2025, is structured with both executive and non-executive members to ensure robust governance and strategic direction. Ralph Elman took over as Non-Executive Chair on January 1, 2025, following Hon. Alexander Hambro's retirement from the Chair role at the close of 2024.

The voting power within Judges Scientific plc is distributed based on ordinary share ownership, with each Ordinary Share carrying one vote. As of July 31, 2025, the company has a total of 6,648,952 Ordinary Shares, representing the total voting rights. The company's governance framework includes the annual re-election of all Directors, a practice implemented from the 2024 Annual General Meeting onwards, adhering to corporate governance best practices. There have been no public reports indicating proxy contests or significant shareholder disputes affecting the company's voting structure.

Understanding Judges Scientific's Voting Power

The ownership structure of Judges Scientific is directly tied to its share capital, with each share granting equal voting rights. This ensures a transparent and equitable distribution of influence among its shareholders.

• All ordinary shares have one vote each.
• Total voting rights stand at 6,648,952 as of July 31, 2025.
• No dual-class share structures are in place.
• Directors are subject to annual re-election.
• This structure supports a clear understanding of Judges Scientific company ownership.

Judges Scientific Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Judges Scientific plc has seen shifts in its leadership and strategic focus over the past few years, maintaining its acquisition-led growth strategy amidst evolving market conditions. The company's ownership structure is influenced by its public trading status and management's reinvestment in the business.

The company's financial performance in the fiscal year ended December 31, 2024, showed a revenue decrease to £133.6 million, a 1.8% drop, and adjusted operating profit fell by 19.8% to £27.9 million. These figures were impacted by external factors such as delays in a Geotek coring expedition and reduced order intake from China. However, organic order intake saw a positive 7% increase in 2024. Acquisitions remain a cornerstone of the company's strategy, with three completed in 2024: Luciol, Rockwash, and Magsputter (Teer Coatings acquired for $15.8 million in August 2024). This aligns with an average of one acquisition per year over the last three years, reflecting a consistent Growth Strategy of Judges Scientific. The company proposed a 10% increase in its final dividend for 2024, amounting to 104.5p per share, underscoring a commitment to shareholder returns. For the first half of 2025, challenges in the US market due to reduced federal research funding led to expectations of lower-than-forecast earnings per share for the full year, despite a 7% increase in organic revenue from a Japanese coring expedition. The company's financial flexibility is supported by an extended and increased banking facility of £140 million, including a £50 million accordion, which provides substantial capacity for future growth initiatives and acquisitions.

Strategic Acquisitions Drive Growth

Judges Scientific plc continues to pursue its 'buy and build' strategy, completing three acquisitions in 2024. This approach aims to enhance market position and diversify revenue streams.

Shareholder Value Focus

The company demonstrated its commitment to shareholders by proposing a 10% increase in the final dividend for 2024. Management's increased stake in August 2025 further signals confidence in the company's prospects.

Navigating Market Headwinds

Despite a revenue dip in 2024 and challenges in the US market in early 2025, the company reported a 7% increase in organic order intake for 2024. This resilience highlights underlying operational strength.

Financial Flexibility for Future Growth

An extended and increased banking facility of £140 million provides Judges Scientific with significant financial resources. This supports ongoing acquisition plans and general corporate purposes.

Judges Scientific Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔